Tumor markers are substances produced by the tumors or by other cells of the body in
response to cancer or certain benign conditions. Although most of these markers are made …

Simple Summary CA27. 29 (MUC1) is a well described biomarker for prediction of prognosis
and treatment efficacy. CA27. 29 is mainly evaluated in the preoperative setting. However …

Results The serum GDF-15 levels were significantly (p< 0.001) elevated in BC patients
compared to healthy controls and in patients with larger tumor size, advanced disease …

Background Most current guidelines do not recommend the serial analysis of tumour marker
CA 15.3 in the follow-up of asymptomatic patients treated for early breast cancer (EBC) …

Objectives: To investigate the circulating levels of microRNA-34a (miRNA-34a) as a novel
non-invasive biomarker of breast cancer (BC). Methods: The case-control study was …

Vascular endothelial growth factor receptor-2 is a dynamic target for therapeutic intervention
in various types of cancers. This study was aimed to explore the anti-angiogenic activity of a …

Background: Breast cancer is the most prevalent cancer and one of the most common
mortality causes among females worldwide. Accordingly, it is a main concern of scientists …

A tumor marker is a substance that is produced by the body in response to malignant tumors,
or produced by the cancer itself. Some of these markers are specific to one cancer, while …

Breast cancer is threatening women all over the world. Invasive and noninvasive breast
cancers have increased with time. According to 2021, 7.8 million women have been living …

Background: The most common malignancy and second most common cause of death is
breast cancer among women. About 2.09 million fatalities from breast cancer happened in …